T2DM Study expression of interest
Thank you for your interest in our Motivational Electronic Interventional Study for Patients with Type 2 Diabetes.
Please fill in and submit your contact details on the form on this page, and we will be in contact with you with details and documentation very shortly.
We need your help in recruiting thirty subjects aged between 45 and 75 years of age who have been diagnosed as type 2 diabetics for > 1 year, and whose HbA1c has been measured in the past year and falls between 7.5% and 9% (58 to 75 mmol/mol). Please see the inclusion and exclusion criteria.
Summary of the study
We have a simple goal in this study: to determine if low-cost, simple and scalable motivation and feedback (using text messages and email) can change exercise and dietary habits of non-insulin using type 2 diabetics, and whether those changes translate to better health and diabetic control outcomes.
The study is a lifestyle intervention study, in which each subject acts as their own control. No therapeutic substances of any type will be added to your treatment of your patients.
If the study does demonstrate such outcomes, it has the potential to be scaled broadly and at low cost to Australians suffering type 2 diabetes to significantly improve health outcomes and reduce diabetic complications and costs to the community.
Each subject will be provided a fitness tracker (Jawbone UP Move) to be worn continuously for 6 months, and their daily step count will be used to provide motivation to increase exercise. The tracker is theirs to keep at the end of the study. Subjects will be provided a diabetic recipe book, and will be registering their meal habits online, where dietary information and recipes will be available. There will be incentives for achievement of goals.
This study is privately funded, has Ethics Committee approval, and is registered with the Australian and New Zealand Clinical Trials Registry (link).
Your practice will be fairly compensated for your involvement in subject selection, and measurements at the start and end of the 6 month trial at $300 per registered subject. Subjects will also be compensated for their participation.
My job, as Principal Investigator, is to provide medical and ethical oversight of the Study, and to ensure subject anonymity and privacy whilst allowing for direct, personalised communications with each subject using text and email.
I encourage your participation. Your contribution will be recognised in the trial outcomes and in any publication arising from this study.
Dr Mark Donohoe MB BS, Principal Investigator